Literature DB >> 24737619

Mimicking the host and its microenvironment in vitro for studying mucosal infections by Pseudomonas aeruginosa.

Aurélie Crabbé1, Maria A Ledesma, Cheryl A Nickerson.   

Abstract

Why is a healthy person protected from Pseudomonas aeruginosa infections, while individuals with cystic fibrosis or damaged epithelium are particularly susceptible to this opportunistic pathogen? To address this question, it is essential to thoroughly understand the dynamic interplay between the host microenvironment and P. aeruginosa. Therefore, using model systems that represent key aspects of human mucosal tissues in health and disease allows recreating in vivo host-pathogen interactions in a physiologically relevant manner. In this review, we discuss how factors of mucosal tissues, such as apical-basolateral polarity, junctional complexes, extracellular matrix proteins, mucus, multicellular complexity (including indigenous microbiota), and other physicochemical factors affect P. aeruginosa pathogenesis and are thus important to mimic in vitro. We highlight in vitro cell and tissue culture model systems of increasing complexity that have been used over the past 35 years to study the infectious disease process of P. aeruginosa, mainly focusing on lung models, and their respective advantages and limitations. Continued improvements of in vitro models based on our expanding knowledge of host microenvironmental factors that participate in P. aeruginosa pathogenesis will help advance fundamental understanding of pathogenic mechanisms and increase the translational potential of research findings from bench to the patient's bedside.
© 2014 Federation of European Microbiological Societies. Published by John Wiley & Sons Ltd. All rights reserved.

Entities:  

Keywords:  cell differentiation; cystic fibrosis; epithelial injury; host-pathogen interactions; microbiome; three-dimensional

Mesh:

Year:  2014        PMID: 24737619      PMCID: PMC4096993          DOI: 10.1111/2049-632X.12180

Source DB:  PubMed          Journal:  Pathog Dis        ISSN: 2049-632X            Impact factor:   3.166


  222 in total

1.  Identification of Pseudomonas aeruginosa flagellin as an adhesin for Muc1 mucin.

Authors:  Erik P Lillehoj; Beom T Kim; K Chul Kim
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2002-04       Impact factor: 5.464

2.  Eradication of Pseudomonas aeruginosa biofilms on cultured airway cells by a fosfomycin/tobramycin antibiotic combination.

Authors:  Gregory G Anderson; Thomas F Kenney; David L Macleod; Noreen R Henig; George A O'Toole
Journal:  Pathog Dis       Date:  2013-01-10       Impact factor: 3.166

3.  Antimicrobial peptide therapeutics for cystic fibrosis.

Authors:  Lijuan Zhang; Jody Parente; Scott M Harris; Donald E Woods; Robert E W Hancock; Timothy J Falla
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

4.  Effect of dietary monosaccharides on Pseudomonas aeruginosa virulence.

Authors:  Ryan K Nelson; Valeriy Poroyko; Michael J Morowitz; Don Liu; John C Alverdy
Journal:  Surg Infect (Larchmt)       Date:  2013-03-01       Impact factor: 2.150

5.  Airway microbiota and pathogen abundance in age-stratified cystic fibrosis patients.

Authors:  Michael J Cox; Martin Allgaier; Byron Taylor; Marshall S Baek; Yvonne J Huang; Rebecca A Daly; Ulas Karaoz; Gary L Andersen; Ronald Brown; Kei E Fujimura; Brian Wu; Diem Tran; Jonathan Koff; Mary Ellen Kleinhenz; Dennis Nielson; Eoin L Brodie; Susan V Lynch
Journal:  PLoS One       Date:  2010-06-23       Impact factor: 3.240

6.  Polarization-dependent apical membrane CFTR targeting underlies cAMP-stimulated Cl- secretion in epithelial cells.

Authors:  A P Morris; S A Cunningham; A Tousson; D J Benos; R A Frizzell
Journal:  Am J Physiol       Date:  1994-01

7.  Effects of human neutrophil elastase and Pseudomonas aeruginosa proteinases on human respiratory epithelium.

Authors:  R Amitani; R Wilson; A Rutman; R Read; C Ward; D Burnett; R A Stockley; P J Cole
Journal:  Am J Respir Cell Mol Biol       Date:  1991-01       Impact factor: 6.914

8.  Increased airway iron as a potential factor in the persistence of Pseudomonas aeruginosa infection in cystic fibrosis.

Authors:  D W Reid; V Carroll; C O'May; A Champion; S M Kirov
Journal:  Eur Respir J       Date:  2007-05-15       Impact factor: 16.671

9.  MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.

Authors:  Markus O Henke; Armin Renner; Rudolf M Huber; Michael C Seeds; Bruce K Rubin
Journal:  Am J Respir Cell Mol Biol       Date:  2004-02-26       Impact factor: 6.914

10.  Pseudomonas aeruginosa cytotoxicity is attenuated at high cell density and associated with the accumulation of phenylacetic acid.

Authors:  Jianhe Wang; Yihu Dong; Tielin Zhou; Xiaoling Liu; Yinyue Deng; Chao Wang; Jasmine Lee; Lian-Hui Zhang
Journal:  PLoS One       Date:  2013-03-29       Impact factor: 3.240

View more
  18 in total

Review 1.  Modeling Host-Pathogen Interactions in the Context of the Microenvironment: Three-Dimensional Cell Culture Comes of Age.

Authors:  Jennifer Barrila; Aurélie Crabbé; Jiseon Yang; Karla Franco; Seth D Nydam; Rebecca J Forsyth; Richard R Davis; Sandhya Gangaraju; C Mark Ott; Carolyn B Coyne; Mina J Bissell; Cheryl A Nickerson
Journal:  Infect Immun       Date:  2018-10-25       Impact factor: 3.441

2.  Interplay between host-microbe and microbe-microbe interactions in cystic fibrosis.

Authors:  Catherine R Armbruster; Tom Coenye; Lhousseine Touqui; Jennifer M Bomberger
Journal:  J Cyst Fibros       Date:  2019-11-02       Impact factor: 5.482

Review 3.  Recent perspectives on the molecular basis of biofilm formation by Pseudomonas aeruginosa and approaches for treatment and biofilm dispersal.

Authors:  Sinosh Skariyachan; Vaishnavi Sneha Sridhar; Swathi Packirisamy; Supreetha Toplar Kumargowda; Sneha Basavaraj Challapilli
Journal:  Folia Microbiol (Praha)       Date:  2018-01-19       Impact factor: 2.099

Review 4.  Pseudomonas aeruginosa Biofilms: Host Response and Clinical Implications in Lung Infections.

Authors:  Nicholas M Maurice; Brahmchetna Bedi; Ruxana T Sadikot
Journal:  Am J Respir Cell Mol Biol       Date:  2018-04       Impact factor: 6.914

5.  Impact of the CFTR-potentiator ivacaftor on airway microbiota in cystic fibrosis patients carrying a G551D mutation.

Authors:  Cédric Bernarde; Marlène Keravec; Jérôme Mounier; Stéphanie Gouriou; Gilles Rault; Claude Férec; Georges Barbier; Geneviève Héry-Arnaud
Journal:  PLoS One       Date:  2015-04-08       Impact factor: 3.240

6.  Three-dimensional organotypic co-culture model of intestinal epithelial cells and macrophages to study Salmonella enterica colonization patterns.

Authors:  Jennifer Barrila; Jiseon Yang; Aurélie Crabbé; Shameema F Sarker; Yulong Liu; C Mark Ott; Mayra A Nelman-Gonzalez; Simon J Clemett; Seth D Nydam; Rebecca J Forsyth; Richard R Davis; Brian E Crucian; Heather Quiriarte; Kenneth L Roland; Karen Brenneman; Clarence Sams; Christine Loscher; Cheryl A Nickerson
Journal:  NPJ Microgravity       Date:  2017-02-28       Impact factor: 4.415

7.  Antimicrobial efficacy against Pseudomonas aeruginosa biofilm formation in a three-dimensional lung epithelial model and the influence of fetal bovine serum.

Authors:  Aurélie Crabbé; Yulong Liu; Nele Matthijs; Petra Rigole; César De La Fuente-Nùñez; Richard Davis; Maria A Ledesma; Shameema Sarker; Rob Van Houdt; Robert E W Hancock; Tom Coenye; Cheryl A Nickerson
Journal:  Sci Rep       Date:  2017-03-03       Impact factor: 4.379

Review 8.  Vaccination against respiratory Pseudomonas aeruginosa infection.

Authors:  Keith Grimwood; Jennelle M Kyd; Suzzanne J Owen; Helen M Massa; Allan W Cripps
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

Review 9.  Is There a Space-Based Technology Solution to Problems with Preclinical Drug Toxicity Testing?

Authors:  Timothy Hammond; Patricia Allen; Holly Birdsall
Journal:  Pharm Res       Date:  2016-05-16       Impact factor: 4.200

Review 10.  Modelling upper respiratory tract diseases: getting grips on host-microbe interactions in chronic rhinosinusitis using in vitro technologies.

Authors:  Charlotte De Rudder; Marta Calatayud Arroyo; Sarah Lebeer; Tom Van de Wiele
Journal:  Microbiome       Date:  2018-04-24       Impact factor: 14.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.